Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hansson

Showing results (441-450 of 671) with videos related to

Pageof 68
Sort By:
Acta Medica Scandinavica|December 1, 1971
Treatment of hypertension with propranolol and hydralazineL Hansson, R Olander, H Aberg, et al.
European Journal of Cardiology|May 1, 1979
Blood cadmium and plasma zinc measurements in acute myocardial infarctionM Ponteva, I Elomaa, H Bäckman, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1974
Hypertension in polycystic kidney diseaseL Hansson, L E Karlander, W Lundgren, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|February 7, 2020
Increased abdominal fat mass and high fat consumption in young school children with congenital heart disease: results from a case-control studyL Hansson, T Lind, I Öhlund, et al.
Journal of Hypertension|September 1, 1990
Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reactionB Dahlöf, D Gustafsson, T Hedner, et al.
Blood Pressure. Supplement|January 1, 1995
Blood pressure and serum lipids in hypertensive men and women aged 60-97 yearsN P Chau, L Hansson, A Petitet, et al.
Lakartidningen|November 9, 1994
[Pravidel may cause pulmonary changes. Signs of inflammatory activity and weight loss are part of the picture]E Vinge, P Odin, L Hansson, et al.
Acta Medica Scandinavica|January 1, 1983
Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonistL Andrén, A Svensson, B Dahlöf, et al.
The Biochemical Journal|February 16, 2007
A proline repeat domain in the Notch co-activator MAML1 is important for the p300-mediated acetylation of MAML1Mariana Saint Just Ribeiro, Magnus L Hansson, Annika E Wallberg
American Journal of Hypertension|June 1, 1996
Remikiren (Ro 42-5892)--an orally active renin inhibitor in essential hypertension. Effects on blood pressure and the renin-angiotensin-aldosterone systemA Himmelmann, A Bergbrant, A Svensson, et al.
Pageof 68

Showing results (441-450 of 671) with videos related to

Sort By:
Pageof 68
Acta Medica Scandinavica|December 1, 1971
Treatment of hypertension with propranolol and hydralazineL Hansson, R Olander, H Aberg, et al.
European Journal of Cardiology|May 1, 1979
Blood cadmium and plasma zinc measurements in acute myocardial infarctionM Ponteva, I Elomaa, H Bäckman, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1974
Hypertension in polycystic kidney diseaseL Hansson, L E Karlander, W Lundgren, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|February 7, 2020
Increased abdominal fat mass and high fat consumption in young school children with congenital heart disease: results from a case-control studyL Hansson, T Lind, I Öhlund, et al.
Journal of Hypertension|September 1, 1990
Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reactionB Dahlöf, D Gustafsson, T Hedner, et al.
Blood Pressure. Supplement|January 1, 1995
Blood pressure and serum lipids in hypertensive men and women aged 60-97 yearsN P Chau, L Hansson, A Petitet, et al.
Lakartidningen|November 9, 1994
[Pravidel may cause pulmonary changes. Signs of inflammatory activity and weight loss are part of the picture]E Vinge, P Odin, L Hansson, et al.
Acta Medica Scandinavica|January 1, 1983
Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonistL Andrén, A Svensson, B Dahlöf, et al.
The Biochemical Journal|February 16, 2007
A proline repeat domain in the Notch co-activator MAML1 is important for the p300-mediated acetylation of MAML1Mariana Saint Just Ribeiro, Magnus L Hansson, Annika E Wallberg
American Journal of Hypertension|June 1, 1996
Remikiren (Ro 42-5892)--an orally active renin inhibitor in essential hypertension. Effects on blood pressure and the renin-angiotensin-aldosterone systemA Himmelmann, A Bergbrant, A Svensson, et al.
Pageof 68